Research Report Screener Results

Chart, Financials, Historical Prices, Industry, Insider, Messages, Profile, Reports, Research, SEC Filings, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 23-Nov-2009
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 45)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
20-Nov-09 New Constructs, LLC N/A SVNT: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Value Graph: SAVIENT PHARM -- SVNT 1 $4 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Industry Value Graph: AEZS , MDCO , QLTI , REGN , SVNT , TECH -- DRUGS 3 $4 View Abstract
19-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299 View Abstract
19-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199 View Abstract
18-Nov-09 Zacks Investment Research Inc. N/A SAVIENT PHARM (SVNT) Zacks Company Snapshot 1 $10 View Abstract
17-Nov-09 EconomicInvestor N/A "The Economy Matters" Report for SVNT: the economy's impact on SVNT's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15 View Abstract
15-Nov-09 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: SAVIENT PHARMACEUTICALS INC 5 $25 View Abstract
10-Nov-09 Zacks Investment Research Inc. N/A SAVIENT PHARM (SVNT) Zacks Company Snapshot 1 $10 View Abstract
8-Nov-09 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: SAVIENT PHARMACEUTICALS INC 5 $25 View Abstract
Next 20

Brokerage Reports (Showing 1 to 10 of 13)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
6-Nov-09 Roth Capital Partners, Inc. Research Department Morning Call Summary 35 $75 View Abstract
5-Nov-09 Collins Stewart LLC Salveen J. Kochnover CFA 3Q09 EPS; Further Clarity on the Manufacturing Process 6 $25 View Abstract
5-Nov-09 Roth Capital Partners, Inc. Scott R. Henry CFA, Andrew Vaino Q3 Earnings Call Ho Hum, Looking For BLA Resubmission In Q1 2010 6 $25 View Abstract
5-Nov-09 Thomson StreetEvents N/A SVNT - Event Transcript of Savient Pharmaceuticals, Inc. conference call, Nov. 05, 2009 / 10:00am ET 17 $75 View Abstract
4-Nov-09 Collins Stewart LLC Salveen J. Kochnover CFA Management Dinner Indicates Krystexxa is on Track 4 $10 View Abstract
29-Oct-09 Roth Capital Partners, Inc. Research Department Morning Call Summary 20 $50 View Abstract
29-Oct-09 Roth Capital Partners, Inc. Scott R. Henry CFA, Andrew Vaino BMRN Smashes Q3 EPS Expectations 6 $25 View Abstract
26-Oct-09 Roth Capital Partners, Inc. Research Department Morning Call Summary 17 $50 View Abstract
26-Oct-09 Roth Capital Partners, Inc. Scott R. Henry CFA, Andrew Vaino Q3 Earnings Preview 28 $75 View Abstract
19-Oct-09 Roth Capital Partners, Inc. Research Department Morning Call Summary 14 $50 View Abstract
Next 3

Independent Reports (Showing 1 to 10 of 32)

Release
Date Contributor Author Title Pages Price More Info
20-Nov-09 New Constructs, LLC N/A SVNT: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Value Graph: SAVIENT PHARM -- SVNT 1 $4 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Industry Value Graph: AEZS , MDCO , QLTI , REGN , SVNT , TECH -- DRUGS 3 $4 View Abstract
19-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299 View Abstract
19-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199 View Abstract
18-Nov-09 Zacks Investment Research Inc. N/A SAVIENT PHARM (SVNT) Zacks Company Snapshot 1 $10 View Abstract
17-Nov-09 EconomicInvestor N/A "The Economy Matters" Report for SVNT: the economy's impact on SVNT's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15 View Abstract
15-Nov-09 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: SAVIENT PHARMACEUTICALS INC 5 $25 View Abstract
10-Nov-09 Zacks Investment Research Inc. N/A SAVIENT PHARM (SVNT) Zacks Company Snapshot 1 $10 View Abstract
8-Nov-09 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: SAVIENT PHARMACEUTICALS INC 5 $25 View Abstract
Next 20

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.